Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Gabriel L. Sardi"'
Autor:
Gabriel L, Sardi, Diljon S, Chahal
Publikováno v:
Cardiovascular Revascularization Medicine. 38:81-82
Autor:
Gabriel L. Sardi, Ivan Pena-Sing
Publikováno v:
Cardiovascular revascularization medicine : including molecular interventions. 21(9)
Autor:
Gabriel L. Sardi
Publikováno v:
Cardiovascular Revascularization Medicine. 24:31-32
Publikováno v:
The Journal of Clinical Hypertension. 14:502-506
Prevalence of the metabolic syndrome (MetS) is high in the United States and is associated with increased risk of cardiovascular disease and diabetes. The authors examined whether the prevalence of the MetS and its components differs across age group
Publikováno v:
J Clin Hypertens (Greenwich)
J Clin Hypertens (Greenwich). 2012;00:00–00. ©2012 Wiley Periodicals, Inc. Prevalence of the metabolic syndrome (MetS) is high in the United States and is associated with increased risk of cardiovascular disease and diabetes. The authors examined
Autor:
Gabriel L, Sardi, Ana, Laynez-Carnicero, Rebecca, Torguson, Zhenyi, Xue, William O, Suddath, Kenneth M, Kent, Lowell F, Satler, Augusto D, Pichard, Joseph, Lindsay, Ron, Waksman
Publikováno v:
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac AngiographyInterventions. 81(6)
This study aimed to compare percutaneous coronary intervention (PCI) with direct stenting (DS) to balloon predilatation (PD) for patients undergoing elective PCI to determine whether there is an independent value for DS with regard to clinical outcom
Autor:
Gabriel L, Sardi, Gabriel, Maluenda, Rebecca, Torguson, Zhenyi, Xue, William O, Suddath, Kenneth M, Kent, Joseph, Lindsay, Lowell F, Satler, Augusto D, Pichard, Ron, Waksman
Publikováno v:
Journal of interventional cardiology. 25(2)
End-stage renal disease (ESRD) is known to correlate with poor outcome in patients undergoing percutaneous coronary intervention (PCI). This study examines the impact of diabetes mellitus (DM) on the long-term outcome of patients with ESRD on chronic
Publikováno v:
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac AngiographyInterventions. 82(4)
This study was undertaken to evaluate the safety of bivalirudin (BIV) use during percutaneous coronary intervention (PCI), following thrombolytic therapy in patients with ST-segment elevation myocardial infarction (STEMI).BIV has emerged as a safer a